• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Research Update on 5-Amino-2-fluoro-4-nitropyridine (CAS: 1807006-29-6) in Chemical Biology and Pharmaceutical Applications

5-Amino-2-fluoro-4-nitropyridine (CAS: 1807006-29-6) has recently emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its versatile reactivity and potential applications in drug discovery. This heterocyclic scaffold, characterized by its amino, fluoro, and nitro functional groups, serves as a key intermediate in the synthesis of bioactive molecules. Recent studies have explored its utility in the development of kinase inhibitors, antimicrobial agents, and fluorescent probes, leveraging its unique electronic properties and structural modularity.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's role as a precursor in the synthesis of selective Bruton's tyrosine kinase (BTK) inhibitors. Researchers optimized the nitropyridine core via palladium-catalyzed cross-coupling reactions, yielding derivatives with nanomolar potency against BTK while maintaining selectivity over other kinases. The fluorine atom at the 2-position was critical for binding affinity, as confirmed by X-ray crystallography of inhibitor-protein complexes.

In antimicrobial applications, 5-Amino-2-fluoro-4-nitropyridine derivatives have shown promising activity against drug-resistant bacterial strains. A team at the University of Tokyo reported novel quinolone hybrids incorporating this scaffold that exhibited 8-16-fold greater potency against methicillin-resistant Staphylococcus aureus (MRSA) compared to existing fluoroquinolones. The nitro group's redox activity was hypothesized to contribute to this enhanced antibacterial effect through reactive oxygen species generation.

The compound's photophysical properties have also been exploited in chemical biology tools. A Nature Communications paper detailed its use as a building block for environment-sensitive fluorescent probes, where the electron-withdrawing nitro group and hydrogen-bonding amino group created a push-pull system responsive to pH changes and protein binding. These probes enabled real-time monitoring of lysosomal dynamics in live cells with unprecedented spatial resolution.

From a synthetic chemistry perspective, recent advances have addressed previous challenges in large-scale production of 1807006-29-6. A continuous flow chemistry approach developed by Merck scientists achieved an 82% yield with >99% purity, overcoming limitations of traditional batch methods that suffered from side reactions involving the reactive nitro group. This technological improvement has facilitated broader investigation of the compound's pharmaceutical potential.

Ongoing research is exploring the scaffold's application in PROTAC (proteolysis targeting chimera) design, where its ability to simultaneously engage target proteins and E3 ubiquitin ligases shows particular promise. Early-stage results presented at the 2023 ACS National Meeting demonstrated successful degradation of several oncology targets using 5-Amino-2-fluoro-4-nitropyridine-based PROTACs with DC50 values below 100 nM.

As the understanding of this compound's chemical biology continues to evolve, its unique combination of electronic properties, synthetic versatility, and bioactivity positions 5-Amino-2-fluoro-4-nitropyridine as a valuable tool for both fundamental research and therapeutic development. Future directions likely include expanded structure-activity relationship studies and investigation of its metabolites for potential off-target effects.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)